Evidence map›Paper›PMID 34890687›Full record

ArticleKidney international2022

Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.

Christophe Masset, Simon Ville, Claire Garandeau, Florent Le Borgne, Thibaut Letellier, Diego Cantarovich, Aurélie Meurette, Cécile Guillot-Gueguen, Maxime Bentoumi-Loaec, Magali Giral and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Observational
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christophe MassetService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France. Electronic address: christophe.masset@chu-nantes.fr.
Simon VilleService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.
Claire GarandeauService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France.
Florent Le BorgneINSERM UMR 1246-SPHERE, Nantes University, Tours University, Nantes, France; IDBC-A2COM Group, Pacé, France.
Thibaut LetellierService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France.
Diego CantarovichService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France.
Aurélie MeuretteService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France.
Cécile Guillot-GueguenService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France.
Maxime Bentoumi-LoaecService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.
Magali GiralService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.
Jacques DantalService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.
Gilles BlanchoService de Néphrologie et Immunologique clinique, Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR 1064, INSERM, Université de Nantes, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 VaccinesKidney TransplantationCOVID-19HumansImmunosuppression TherapySARS-CoV-2Transplant RecipientsVaccinationCOVID-19 Vaccines

Identifiers

PMID34890687
PMCPMC8651481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.